ロード中...
Thrombin Generation Profile in Various Lymphoma Sub-Groups and Its Augmentation by Andexanet Alfa
The prevalence of thrombosis in lymphoma patients is reportedly high and ranges from 3-10%. Vascular malfunction and inflammatory processes further contribute to the thrombotic activation process in these patients. Andexanet alfa (AA) is an antidote for factor Xa inhibitors and its usage has been re...
保存先:
| 出版年: | Clin Appl Thromb Hemost |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7783880/ https://ncbi.nlm.nih.gov/pubmed/33372544 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1076029620983466 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|